Drug Patents owned by Abbvie Endocrine Inc
1. Drug name - LUPRON DEPOT
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8921326 | ABBVIE ENDOCRINE INC | Sustained-release composition and method for producing the same |
Feb, 2031
(8 years from now) | |
Drugs and Companies using LEUPROLIDE ACETATE ingredient
Treatment: Palliative treatment of prostate cancer
Dosage: INJECTABLE;INJECTION
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 22.5MG/VIAL | INJECTABLE;INJECTION | Prescription |
| 30MG/VIAL | INJECTABLE;INJECTION | Prescription |
| 45MG/VIAL | INJECTABLE;INJECTION | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.